CMS’ proposed 2027 Physician Fee Schedule would block Medicare reimbursement for remote patient monitoring delivered by third-party vendors. The policy is tied to Office of Inspector General findings flagging widespread fraud in the remote monitoring space. The reporting describes this as a direct payment and access shift for remote monitoring platforms that rely on third-party service models—potentially forcing providers and vendors to restructure operations around allowed billing pathways. For biotech and med-tech-adjacent stakeholders, the change matters because remote monitoring increasingly intersects with post-acute care pathways, drug adherence programs, and clinical trial decentralization initiatives. The policy proposal raises the stakes for compliance-by-design systems.